Covaxin safe for kids: Bharat Biotech

Covaxin has become the only Covid-19 vaccine in the world to have studied and generated data from trials on kids as young as two years. Results of the trial showed seroconversion at 95-98% in children of all age groups, four weeks after they received their second dose.

from Times of India https://timesofindia.indiatimes.com/india/covaxin-safe-for-kids-showed-better-response-than-in-adults-bharat-biotech/articleshow/88601133.cms